SGTX NASDAQ
Sigilon Therapeutics, Inc.
1W: +0.0%
1M: +5.0%
3M: +200.4%
1Y: +152.2%
$22.47
Last traded 2023-08-18 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$87M
-39.5% ▼
4Y CAGR: +6.6%
Total Liabilities
$48M
-28.4% ▼
4Y CAGR: -17.5%
Shareholders Equity
$39M
-49.3% ▼
Cash & Investments
$70M
-43.6% ▼
4Y CAGR: +2.1%
Total Debt
$28M
-16.2% ▼
4Y CAGR: +54.3%
Net Debt
-$14M
+81.0% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $64M | $76M | $202M | $107M | $42M |
| Short-Term Investments | $0 | $0 | $0 | $16M | $28M |
| Cash & ST Investments | $64M | $76M | $202M | $123M | $70M |
| Net Receivables | $0 | $136K | $177K | $59K | $3M |
| Inventory | $0 | $0 | $75K | $250K | $250K |
| Other Current Assets | $422K | $732K | $2M | $3M | $1M |
| Total Current Assets | $65M | $77M | $204M | $126M | $74M |
| Property, Plant & Equip. | $3M | $13M | $20M | $17M | $12M |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $576K | $641K | $1M | $1M | $1M |
| Total Non-Current Assets | $3M | $13M | $21M | $18M | $13M |
| Total Assets | $68M | $90M | $225M | $144M | $87M |
| — Liabilities — | |||||
| Accounts Payable | $2M | $2M | $2M | $2M | $936K |
| Short-Term Debt | $667K | $3M | $5M | $7M | $11M |
| Deferred Revenue | $25M | $29M | $32M | $17M | $13M |
| Other Current Liabilities | $2M | $6M | $8M | $9M | $6M |
| Total Current Liabilities | $29M | $40M | $47M | $35M | $31M |
| Long-Term Debt | $4M | $22M | $32M | $27M | $17M |
| Other Non-Current Liab. | $59K | $91M | $176K | $0 | $233K |
| Total Non-Current Liabilities | $75M | $128M | $32M | $32M | $17M |
| Total Liabilities | $104M | $168M | $79M | $67M | $48M |
| — Equity — | |||||
| Common Stock | $5K | $5K | $31K | $32K | $32K |
| Retained Earnings | -$37M | -$81M | -$136M | -$213M | -$257M |
| Accumulated OCI | -$515K | $0 | -$225M | -$10K | -$429K |
| Total Stockholders Equity | -$36M | -$78M | $146M | $77M | $39M |
| Total Liabilities & Equity | $68M | $90M | $225M | $144M | $87M |
| — Key Metrics — | |||||
| Total Debt | $5M | $25M | $37M | $34M | $28M |
| Net Debt | -$59M | -$51M | -$165M | -$74M | -$14M |
| Total Investments | $0 | $0 | $0 | $16M | $28M |